Migraine
Michael Fort, Synexus' Chief Executive said "As a clinical research company, our goals (patient care, improvements in medication and treatment, plus forward-thinking research) show a cohesive synergy with those of Migraine Action, which we feel makes this relationship an ideal link for both organisations.
We have been talking to Migraine Action for some months and are delighted that our discussions have resulted in such a positive outcome. Both organisations believe that we can improve our members/patients' care, treatment and health, and at the end of the day that is what really matters to us all"
Have more questions? Contact us for more information
